Omega Healthcare Investors, Inc. Stock

Equities

OHI

US6819361006

Specialized REITs

Market Closed - Nyse 16:00:01 2024-07-19 EDT 5-day change 1st Jan Change
35.91 USD 0.00% Intraday chart for Omega Healthcare Investors, Inc. +4.15% +17.12%
Sales 2024 * 837M 1.15B Sales 2025 * 887M 1.22B Capitalization 8.87B 12.18B
Net income 2024 * 338M 464M Net income 2025 * 389M 534M EV / Sales 2024 * 16.4 x
Net Debt 2024 * 4.87B 6.68B Net Debt 2025 * 5.02B 6.9B EV / Sales 2025 * 15.7 x
P/E ratio 2024 *
26.5 x
P/E ratio 2025 *
23.5 x
Employees 57
Yield 2024 *
7.46%
Yield 2025 *
7.48%
Free-Float 99.63%
More Fundamentals * Estimated data
Dynamic Chart
Scotiabank Adjusts Price Target on Omega Healthcare Investors to $33 From $32, Maintains Sector Perform Rating MT
Truist Securities Adjusts Omega Healthcare Investors Price Target to $33 From $32, Maintains Hold Rating MT
Deutsche Bank Adjusts Omega Healthcare Investors Price Target to $38 From $36, Maintains Buy Rating MT
RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating MT
Tranche Update on Omega Healthcare Investors, Inc.'s Equity Buyback Plan announced on January 27, 2022. CI
Transcript : Omega Healthcare Investors, Inc., Q1 2024 Earnings Call, May 03, 2024
Omega Healthcare Investors Q1 Adjusted Funds From Operations, Revenue Rise MT
Earnings Flash (OHI) OMEGA HEALTHCARE INVESTORS Posts Q1 Revenue $243.3M MT
Omega Healthcare Investors, Inc. Announces Impairment Charges for the Three Months Ended March 31, 2024 CI
Omega Healthcare Investors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Omega Healthcare Investors, Inc. acquired 32 Facilities in the U.K. for $62.7 million. CI
Omega Healthcare Investors Maintains Quarterly Dividend at $0.67 Per Share; Payable May 15 to Shareholders of Record April 30 MT
Omega Healthcare Investors, Inc. Announces Quarterly Cash Dividend Payable on May 15, 2024 CI
Truist Securities Raises Price Target on Omega Healthcare Investors to $32 From $31, Maintains Hold Rating MT
North American Morning Briefing : Tech in Focus on -2- DJ
More news
1 week+4.15%
Current month+4.85%
1 month+9.82%
3 months+18.05%
6 months+20.99%
Current year+17.12%
More quotes
1 week
34.63
Extreme 34.63
36.14
1 month
32.92
Extreme 32.92
36.14
Current year
27.53
Extreme 27.5294
36.14
1 year
27.53
Extreme 27.5294
36.14
3 years
24.81
Extreme 24.81
37.72
5 years
13.33
Extreme 13.33
45.22
10 years
13.33
Extreme 13.33
45.46
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 01-05-31
Director of Finance/CFO 61 01-07-31
Chief Operating Officer 61 01-09-30
Members of the board TitleAgeSince
Director/Board Member 64 00-07-16
Chief Executive Officer 62 01-05-31
Chairman 68 13-03-31
More insiders
Date Price Change Volume
24-07-19 35.91 0.00% 1,303,242
24-07-18 35.91 +0.31% 1,924,667
24-07-17 35.8 +0.28% 1,656,614
24-07-16 35.7 +2.09% 2,078,346
24-07-15 34.97 +1.42% 1,267,095

Delayed Quote Nyse, July 19, 2024 at 04:00 pm

More quotes
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 891 healthcare facilities, located in 42 states and the United Kingdom that are operated by 74 third-party operators.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
35.91 USD
Average target price
33.86 USD
Spread / Average Target
-5.72%
Consensus